Autografting in myeloma patients with renal impairment

被引：0
|
作者：
Raje, N [1 ]
Powles, R [1 ]
Kulkarni, S [1 ]
Milan, S [1 ]
Middleton, G [1 ]
Eisen, T [1 ]
Treleaven, J [1 ]
机构：
[1] ROYAL MARSDEN HOSP,SUTTON SM2 5PT,SURREY,ENGLAND
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3872 / 3872
页数：1
相关论文
共 50 条
  • [31] Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment
    Jian, Yuan
    Chang, Long
    Shi, Ming-Xia
    Sun, Ying
    Chu, Xiao-Xia
    Xue, Hua
    Huang, Wen-Rong
    Shen, Xu-Liang
    Ma, Jie
    Jia, Guo-Rong
    Feng, Ya-Qing
    Xi, Zhen-Fang
    Zhao, Yan-Hong
    Ma, Yan-Ping
    Xiao, Jing
    Ma, Guang-Yu
    Wang, Qing-Ming
    Bao, Li
    Dong, Yu-Jun
    Zhou, He-Bing
    Sun, Chun-Yan
    Su, Guo-Hong
    Yan, Yan
    Qimuge, Sai-Yin
    Su, Li-Ping
    Sun, Jing-Nan
    Tian, Wei-Wei
    Sun, Xiu-Li
    Ing, Hong-Mei
    Gao, Da
    Chen, Wen-Ming
    Li, Jian
    Gao, Wen
    BLOOD ADVANCES, 2023, 7 (24) : 7581 - 7584
  • [32] An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment
    Dimopoulos, Meletios A.
    Mikhael, Joseph
    Terpos, Evangelos
    Leleu, Xavier
    Moreau, Philippe
    Blade, Joan
    Kim, Jin Seok
    Stockerl-Goldstein, Keith
    Richardson, Paul G.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [33] Impact of Renal Impairment Criteria on Survival of Patients With Newly Diagnosed Multiple Myeloma
    Strufaldi, Fernando L.
    Segura, Gabriela C.
    Caires, Renato A.
    Mattedi, Francisco Z.
    Costalonga, Elerson
    Martinez, Gracia
    Costa e Silva, Veronica T.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 643 - 643
  • [34] Peripheral blood progenitor cell autografting in patients with multiple myeloma.
    Goldschmidt, H
    Hegenbart, U
    Egerer, G
    Fruhauf, S
    Voso, MT
    Hohaus, S
    Wannenmacher, M
    Haas, R
    BLOOD, 1997, 90 (10) : 1707 - 1707
  • [35] Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma
    Henley, D
    Kaye, J
    Walsh, J
    Cull, G
    INTERNAL MEDICINE JOURNAL, 2005, 35 (12) : 726 - 728
  • [36] Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment
    Jung, Sung-Hoon
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Cho, Min-Seok
    Kim, Jae-Yong
    Ahn, Seo-Yeon
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    BLOOD RESEARCH, 2015, 50 (03) : 167 - 172
  • [37] Evaluation of the Safety and Efficacy of Denosumab in Patients With Multiple Myeloma and Severe Renal Impairment
    Terpos, Evangelos
    Ntanasis-Stathopoulos, Ioannis
    Kyriakou, Charalampia
    Tan, Carlyn
    Abildgaard, Niels
    Delforge, Michel
    Fantl, Dorotea
    Usmani, Saad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S198 - S199
  • [38] Renal Impairment in Multiple Myeloma: Time Is of the Essence
    Hutchison, Colin A.
    Bridoux, Frank
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (11) : E312 - E313
  • [39] Current Trends of Renal Impairment in Multiple Myeloma
    Yadav, Punit
    Cook, Mark
    Cockwell, Paul
    KIDNEY DISEASES, 2016, 1 (04) : 241 - 257
  • [40] Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma
    Kobayashi, Hiroki
    Terao, Toshiki
    Tsushima, Takafumi
    Abe, Yoshiaki
    Miura, Daisuke
    Narita, Kentaro
    Kitadate, Akihiro
    Takeuchi, Masami
    Matsue, Kosei
    CANCER MEDICINE, 2020, 9 (12): : 4460 - 4466
12345